The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Srebp-controlled glucose metabolism is essential for NK cell functional responses
Open accessAbstract
Activated natural killer (NK) cells engage in a robust metabolic response that is required for normal effector function. Using genetic, pharmacological and metabolic analyses, we demonstrated an essential role for Srebp transcription factors in cytokine-induced metabolic reprogramming of NK cells that was independent of their conventional role in the control of lipid synthesis. Srebp was required for elevated glycolysis and oxidative phosphorylation and promoted a distinct metabolic pathway configuration in which glucose was metabolized to cytosolic citrate via the citrate-malate shuttle. Preventing the activation of Srebp or direct inhibition of the citrate-malate shuttle inhibited production of interferon-γ and NK cell cytotoxicity. Thus, Srebp controls glucose metabolism in NK cells, and this Srebp-dependent regulation is critical for NK cell effector function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“More recently, it was demonstrated that the citrate–malate shuttle performs functions beyond that of an electron shuttle and, in fact, supports continuous citrate regeneration and TCA cycle intermediate homeostasis (119, 121).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [119]
Citations
Cites
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity
Cheng, S.-C., Quintin, J., Cramer, R. A., Shepardson, K. M., Saeed, S., Kumar, V., Giamarellos-Bourboulis, E. J., Martens, J. H. A., Rao, N. A., Aghajanirefah, A., et al. (2014) · Science · doi:10.1126/science.1250684 · Cited by 2,224
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020
Caligiuri, M. A. (2008) · Blood · doi:10.1182/blood-2007-09-077438 · Cited by 1,980
Fueling Immunity: Insights into Metabolism and Lymphocyte Function
Pearce, E. L., Poffenberger, M. C., Chang, C.-H., & Jones, R. G. (2013) · Science · doi:10.1126/science.1242454 · Cited by 1,363
Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages
Huang, S. C., Everts, B., Ivanova, Y., O’Sullivan, D., Nascimento, M., Smith, A. M., Beatty, W. L., Love-Gregory, L. D., Lam, W. Y., O’Neill, C. M., et al. (2014) · Nature Immunology · doi:10.1038/ni.2956 · Cited by 1,256
Targeting natural killer cells in cancer immunotherapy
Guillerey, C., Huntington, N. D., & Smyth, M. J. (2016) · Nature Immunology · doi:10.1038/ni.3518 · Cited by 1,081
Global burden of cancer attributable to high body-mass index in 2012: a population-based study
Arnold, M., Pandeya, N., Byrnes, G. B., Renehan, A. G., Stevens, G. A., Ezzati, M., Ferlay, J., Miranda, J. J., Romieu, I., Dikshit, R. P., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71123-4 · Cited by 997
De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells
Berod, L., Friedrich, C., Nandan, A., Freitag, J., Hagemann, S., Harmrolfs, K., Sandouk, A., Hesse, C., Castro, C. N., Bähre, H., et al. (2014) · Nature Medicine · doi:10.1038/nm.3704 · Cited by 927
Cited by
Sorted by citations
Items 201–300 of 375
Fatty acids are crucial to fuel NK cells upon acute retrovirus infection
Schimmer, S., Mittermüller, D., Werner, T., Görs, P. E., Meckelmann, S. W., Finlay, D. K., Dittmer, U., & Littwitz-Salomon, E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1296355 · Cited by 20
Self-citationMetabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy
Chen, C., Han, P., & Qing, Y. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103579 · Cited by 17
Targeting glutamine metabolism crosstalk with tumor immune response
Dong, C., Zhao, Y., Han, Y., Li, M., & Wang, G. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189257 · Cited by 21
TGFβ drives mitochondrial dysfunction in peripheral blood NK cells during metastatic breast cancerPreprint
Slattery, K., Zaiatz-Bittencourt, V., Woods, E., Brennan, K., Marks, S. J., Chew, S. M., Conroy, M. R., Goggin, C., Kennedy, J., Finlay, D. K., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/648501 · Cited by 17
Self-citationMetabolic reprogramming of NK cells drives anti-tumor immunity
Yang, P., Wang, W., Liu, Q., Mu, S., Zha, Y., Yan, W., Yuan, B., & Yang, J. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104859 · Cited by 20
Choline in immunity: a key regulator of immune cell activation and function
Maia, C., Fung, C. W., & Sánchez‐López, E. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1617077 · Cited by 18
Immune and metabolic checkpoints blockade: Dual wielding against tumors
Kazemi, M. H., Najafi, A., Karami, J., Ghazizadeh, F., Yousefi, H., Falak, R., & Safari, E. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107461 · Cited by 16
NK cells vs. obesity: A tale of dysfunction & redemption
Barra, C. D., O'Shea, D. B., & Hogan, A. E. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109744 · Cited by 17
Shen, H., Liu, B., He, J., Zhao, W., Li, W., Ma, L., Hou, L., Wáng, Y., Jin, C., Chang, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202509989 · Cited by 16
Chen, H., Sun, Y., Yang, Z., Yin, S., Li, Y., Tang, M., Zhu, J.-P., & Zhang, F. (2021) · Oncology Reports · doi:10.3892/or.2021.7946 · Cited by 15
dos Reis, L. M., Berçot, M. R., Castelucci, B. G., Martins, A. J. E., Castro, G., & Moraes‐Vieira, P. M. (2023) · Viruses · doi:10.3390/v15020525 · Cited by 17
Kim, H., Choi, I. A., Umemoto, A., Bae, S., Kaneko, K., Mizuno, M., Γιαννοπούλου, Ε., Pannellini, T., Deng, L., & Park‐Min, K. (2024) · Bone Research · doi:10.1038/s41413-024-00354-4 · Cited by 15
Hhex Directly Represses BIM-Dependent Apoptosis to Promote NK Cell Development and Maintenance
Goh, W., Scheer, S., Jackson, J. T., Hediyeh-zadeh, S., Delconte, R. B., Schuster, I. S., Andoniou, C. E., Rautela, J., Degli‐Esposti, M. A., Davis, M. J., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108285 · Cited by 15
Metabolic interventions: A new insight into the cancer immunotherapy
Yu, T., Dong, T., Eyvani, H., Fang, Y., Wang, X., Zhang, X., & Lu, X. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108659 · Cited by 16
Kedia-Mehta, N., Choi, C., McCrudden, A., Littwitz-Salomon, E., Fox, P. G., Gardiner, C. M., & Finlay, D. K. (2019) · PubMed · doi:10.20900/immunometab20190014 · Cited by 15
Self-citationUnraveling the complexities of diet induced obesity and glucolipid dysfunction in metabolic syndrome
Dutta, B., Tripathy, A., Archana, P. R., & Kamath, S. U. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01837-y · Cited by 19
An, M., Yan, J., Liu, B., & Liu, Q. (2026) · 癌症:英文版 · doi:10.34133/cancomm.0023 · Cited by 17
NK cell immunometabolism as target for liver cancer therapy
Wang, J., Liu, X., Jin, T., Cao, Y., Tian, Y., & Xu, F. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109193 · Cited by 14
Advanced nanomaterials for enhanced immunotherapy via metabolic regulation
Li, X., Ding, B., Zheng, P., Ma, P., & Lin, J. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215540 · Cited by 14
Pan, W., Tao, T., Qiu, Y., Zhu, X. M., & Zhou, X. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104231 · Cited by 16
Powering immunity: mitochondrial dynamics in natural killer cells
Verhezen, T., Wouters, A., Smits, E., & Waele, J. D. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.04.004 · Cited by 13
ACLY-matizing Macrophages to Histone Modification during Immunometabolic Reprogramming
Williams, N. C., & O'Neill, L. A. J. (2020) · Trends in Immunology · doi:10.1016/j.it.2019.12.009 · Cited by 14
Khan, A. U. H., Almutairi, S. M., Ali, A. K., Salcedo, R., Stewart, C. A., Wang, L., & Lee, S.-H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.654225 · Cited by 14
Lu, Y., Zhang, Z., Wang, S., Qi, Y., Chen, F., Xu, Y., Shen, M., Chen, M., Chen, N., Yang, L., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.01.011 · Cited by 15
Cutting edge: Metabolic immune reprogramming, reactive oxygen species, and cancer
Aria, H., Ghaedrahmati, F., & Ganjalıkhani-Hakemi, M. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30303 · Cited by 14
Tissue-Specific Metabolic Reprogramming in Innate Lymphoid Cells and Its Impact on Disease
Ham, J., Yang, W., & Kim, H. Y. (2025) · Immune Network · doi:10.4110/in.2025.25.e3 · Cited by 13
Anti‐Tumor Strategies Targeting Nutritional Deprivation: Challenges and Opportunities
Shi, J., Han, W., Wang, J., & Kong, X. (2025) · Advanced Materials · doi:10.1002/adma.202415550 · Cited by 14
Yu, Y., Wang, Z., Yang, A., Wang, Y., Bao, C., Li, Z., Han, Q., Zhao, H., & Zhang, J. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08069-y · Cited by 12
Metabolic regulation of NK cell antiviral functions during cytomegalovirus infection
Cimpean, M., & Cooper, M. A. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad018 · Cited by 12
Zara, V., Assalve, G., & Ferramosca, A. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166758 · Cited by 12
Tuning cellular metabolism for cancer virotherapy
Xiong, D., Wang, Q., Wang, W., & Sun, Z. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216924 · Cited by 12
Puertas-Umbert, L., Alonso, J., Blanco-Casoliva, L., Almendra‐Pegueros, R., Camacho, M., Rodríguez‐Sinovas, A., Galán, M., Roglans, N., Laguna, J. C., Martínez‐González, J., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117876 · Cited by 12
Velásquez, S. Y., Himmelhan, B. S., Kassner, N., Coulibaly, A., Schulte, J., Brohm, K., & Lindner, H. A. (2020) · Cells · doi:10.3390/cells9030734 · Cited by 12
Decreased glycolysis induced dysfunction of NK cells in Henoch-Schonlein purpura patients
Chai, W., Wang, X., Wang, W., Wang, H., Mou, W., & Gui, J. (2020) · BMC Immunology · doi:10.1186/s12865-020-00382-9 · Cited by 12
Zhou, Y., Zhang, A., Fang, C., Yuan, L., Shao, A., Xu, Y., & Zhou, D. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14315 · Cited by 12
Metabolic programming of organ‐specific natural killer cell responses
Delconte, R. B., & Sun, J. C.-Y. (2024) · Immunological Reviews · doi:10.1111/imr.13333 · Cited by 12
Overview of Strategies to Improve Therapy against Tumors Using Natural Killer Cell
Yang, C.-P., Li, Y., Yang, Y.-Z., & Chen, Z. (2020) · Journal of Immunological Research · doi:10.1155/2020/8459496 · Cited by 13
Chen, K., Wang, W., Shu, H.-Y., Lyu, J., Cui, W., & Fang, H. (2025) · Interdisciplinary medicine · doi:10.1002/inmd.70054 · Cited by 11
Unraveling the mystery of citrate transporters in Alzheimer’s disease: An updated review
Mukherjee, A. G., Mishra, S., Gopalakrishnan, A. V., Kannampuzha, S., Murali, R., Wanjari, U. R., Stany, B. K., Vellingiri, B., Madhyastha, H., Deepankumar, K., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102726 · Cited by 11
Polyamines in pancreatic cancer: reshaping the immunosuppressive tumor microenvironment
Jiang, S., Ren, B., Ding, C., Du, C., Cao, Z., Yang, G., Huang, H., & Zhang, T. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218016 · Cited by 12
Natural Killer Cell‐Mediated Antitumor Immunity: Molecular Mechanisms and Clinical Applications
Luo, N., Chen, C., Zhou, W., Hao, J., He, S., Liu, Y., Ku, Y., Huang, L., Zhang, C., Shu, Y., et al. (2025) · MedComm · doi:10.1002/mco2.70387 · Cited by 12
Immuno-onco-metabolism and Therapeutic Resistance
Mir, M. A., Aisha, S., Nisar, S., Qayoom, H., & Mehraj, U. (2022) · Springer eBooks · doi:10.1007/978-981-16-6226-3_3 · Cited by 11
Alpha‐ketoglutaric acid based polymeric particles for cutaneous wound healing
Jaggarapu, M. M. C. S., Ghosh, D., Johnston, T. M., Yaron, J. R., Mangal, J. L., Inamdar, S., Gosangi, M., Rege, K., & Acharya, A. P. (2023) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37539 · Cited by 11
Rao, Y., Gai, X., Le, Y., Xiong, J., Liu, Y., Zhang, X., Wang, J., Cao, W., & Sun, Y. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.799276 · Cited by 11
Lactic acid: a narrative review of a promoter of the liver cancer microenvironment
Chen, J., He, G., Cai, D., Giovannetti, E., Inamura, K., Liu, S., & Ma, W. (2024) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-24-368 · Cited by 10
Fatty acid metabolism: A new target for nasopharyngeal carcinoma therapy
Li, J., Ping, P., Li, Y., & Xu, X. (2024) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2024.06.05 · Cited by 10
Unique metabolism and protein expression signature in human decidual NK cells
Wang, P., Liang, T., Zhan, H., Zhu, M., Wu, M., Qian, L., Zhou, Y. Y., & Ni, F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1136652 · Cited by 9
No time to die: Epigenetic regulation of natural killer cell survival
Hermans, L., & O’Sullivan, T. E. (2024) · Immunological Reviews · doi:10.1111/imr.13314 · Cited by 9
Ying, D., Zhang, G., Huang, H., Tan, W., & Cai, H. (2024) · Biotechnology Progress · doi:10.1002/btpr.3464 · Cited by 9
Li, K., Wang, H., Li, C., Xiao, M., Luo, Y., Shen, S., Li, G., Fu, Y., Chen, W., Shao, R., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08877-0 · Cited by 9
Santo, V., Brunetti, L., Pecci, F., Peroni, M., Barnini, G., Paoloni, F., Buti, S., Tiseo, M., Ricciuti, B., Pinato, D. J., et al. (2025) · Current Oncology Reports · doi:10.1007/s11912-025-01718-7 · Cited by 10
Pecci, F., Cognigni, V., Giudice, G. C., Paoloni, F., Cantini, L., Saini, K. S., Abushukair, H. M., Naqash, A. R., Cortellini, A., Mazzaschi, G., et al. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104654 · Cited by 9
David, J., O'Toole, E., O'Reilly, K., Thuery, G., Aßmann, N., Finlay, D. K., & Harkin, A. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.09.023 · Cited by 9
Self-citationZeng, X., Dong, X., Ma, Y., & Yao, J. (2022) · Cell Biology and Toxicology · doi:10.1007/s10565-022-09708-2 · Cited by 9
Aspartate availability drives differential engagement of the malate-aspartate shuttle
Brunner, J. S., Bridgeman, A. E., Jackson, B. T., Chakraborty, S., Fagoaga-Eugui, M., Paras, K. I., Xie, A., Arnold, P. K., Losner, J., & Finley, L. W. S. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.02.004 · Cited by 8
Citrate clearance is a major function of aconitase 2 in the canonical TCA cycle
Xie, A., Brunner, J. S., Chakraborty, S., Montero, A. M., Bridgeman, A. E., Paras, K. I., Cui, R., Fagoaga-Eugui, M., Komza, M., Arnold, P. K., et al. (2026) · Cell · doi:10.1016/j.cell.2026.01.028 · Cited by 12
Recent advancements in nanomedicine based lipid metabolism for tumour immunotherapy
Zhao, Y., Zhang, X., An, M., Zhang, J., & Liu, Y. (2023) · Journal of drug targeting · doi:10.1080/1061186x.2023.2283829 · Cited by 8
Approaches to investigate tissue-resident innate lymphocytes metabolism at the single-cell level
Corkish, C., de Aguiar, C. F., & Finlay, D. K. (2024) · Nature Communications · doi:10.1038/s41467-024-54516-3 · Cited by 8
Self-citationDeciphering metabolic crosstalk in context: lessons from inflammatory diseases
Verheijen, F. W., Minh, T. T. N., Chang, J., Broere, F., Zaal, E. A., & Berkers, C. R. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13588 · Cited by 8
Phenotypes, mechanisms, and therapeutic strategies of natural killer cell immunosenescence
Guo, Z., Wu, F., Chen, Y., Xu, J. M., & Chen, Z. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00534-8 · Cited by 9
Vitamin combination promotes ex vivo expansion of NK-92 cells by reprogramming glucose metabolism
Fu, Y., Chen, Y., Xie, Z., Huang, H., Tan, W., & Cai, H. (2022) · Bioresources and Bioprocessing · doi:10.1186/s40643-022-00578-4 · Cited by 7
Chen, S., Liu, J., He, G. Q., Tang, N., & Zeng, Y. (2024) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s495330 · Cited by 7
Barbaro, A. D. L., Palano, M. T., Cucchiara, M., Gallazzi, M., Mortara, L., & Bruno, A. (2021) · Vaccines · doi:10.3390/vaccines9101178 · Cited by 7
Yang, Q., Zhang, S., Wu, S., Yao, B., Wang, L., Li, Y., Peng, H., Huang, M., Bi, Q., Xiong, P., et al. (2022) · Immunologic Research · doi:10.1007/s12026-022-09266-z · Cited by 7
NK Cell Metabolism and the Potential Offered for Cancer Immunotherapy
Gardiner, C. M. (2019) · Immunometabolism · doi:10.20900/immunometab20190005 · Cited by 7
Self-citationAutofluorescence lifetime imaging classifies human lymphocyte activation and subtypePreprint
Schmitz, R. L., Tweed, K. E., Rehani, P. R., Samimi, K., Riendeau, J. M., Jones, I., Maly, E. M., Guzman, E. C., Forsberg, M. H., Shahi, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.23.525260 · Cited by 7
Molecular Targets for Cannabinoids in Natural Killer Cells: Do They Modulate the Antitumor Activity?
Olivas-Aguirre, M., Gutiérrez-Iñiguez, C., Pottosin, I. I., & Dobrovinskaya, O. R. (2024) · Receptors · doi:10.3390/receptors3020007 · Cited by 6
The role of immune cells glycolysis in neuroinflammation secondary to intracerebral hemorrhage
Luo, B., Liu, S., Zheng, L., Zhang, B., Shang, Y., Shang, T., Zheng, J., Kuang, B., & Zou, W. (2025) · Clinical Immunology · doi:10.1016/j.clim.2025.110543 · Cited by 7
Effects of Rapid Weight Loss on the Immune System in Combat Sports Athletes: A Systematic Review
Lee, H. S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27010508 · Cited by 6
Tubular insulin-induced gene 1 deficiency promotes NAD+ consumption and exacerbates kidney fibrosis
Li, S., Qin, J., Zhao, Y., Wang, J., Huang, S., & Yu, X. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00081-7 · Cited by 6
Pesini, C., Artal, L., Bernal, J. P., Sánchez‐Martínez, D., Pardo, J., & Ramírez-Labrada, A. (2024) · OncoImmunology · doi:10.1080/2162402x.2024.2379062 · Cited by 6
Nedel, W. L., Strogulski, N. R., Rodolphi, M. S., Kopczynski, A., Montes, T. H. M., & Portela, L. V. (2022) · Shock · doi:10.1097/shk.0000000000002055 · Cited by 6
Local and systemic features of ILC immunometabolism
Surace, L., & Santo, J. P. D. (2022) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000722 · Cited by 6
Leptin, NK cells, and the weight of immunity: Insights into obesity
de Andrade, A. G., Vanderley, S. E. R., Marques, L. C. D. S., Almeida, F. S., Silva, L. H. A. C., & Keesen, T. S. L. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113992 · Cited by 7
ACLY promotes NK cell effector function by regulating glycolysis and histone acetylation
Sohn, H., Kolicheski, A., Poursine‐Laurent, J., Tran, J., Wang, Y., Gan, K., Tobin, J. M., Saucier, N., Fehniger, T. A., Payton, J. E., et al. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf209 · Cited by 6
Natural killer cells in kidney immune surveillance, injury and fibrosis
Horowitz, A., & Heeger, P. S. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-025-01029-x · Cited by 6
Metabolic requirements of CD160 expressing memory‐like NK cells in Gram‐negative bacterial infection
Preechanukul, A., Saiprom, N., Rochaikun, K., Moonmueangsan, B., Phunpang, R., Ottiwet, O., Kongphrai, Y., Wapee, S., Janon, R., Dunachie, S. J., et al. (2024) · Clinical & Translational Immunology · doi:10.1002/cti2.1513 · Cited by 5
Non-Specific Elevated Serum Free Fatty Acids in Lung Cancer Patients: Nutritional or Pathological?
Shao, Y., Wang, S., Xu, X., Sun, C., Cai, F., Guo, Q., Wu, M., Yang, M., & Wu, X. (2024) · Nutrients · doi:10.3390/nu16172884 · Cited by 5
Pharmacological therapy targeting the immune response in atherosclerosis
Wu, Y., Xu, Y., & Xu, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112974 · Cited by 5
Zheng, X., Huang, Z., Liu, Z., Zheng, Z., Zhang, Y., & Aweya, J. J. (2022) · Genes · doi:10.3390/genes13112057 · Cited by 6
Schimmer, S., Kerkmann, L., Kahlert, N., Jubeh, S. A., Werner, T., Corkish, C., Prendeville, H., Finlay, D. K., Sutter, K., Dittmer, U., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112396 · Cited by 4
Self-citationYang, K., Bi, J., Cao, Y., He, D., Fu, S., & Guo, W. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.03.048 · Cited by 4
Natural killer cell exhaustion in ovarian cancer: from molecular suppression to therapeutic revival
Ning, J., & Yao, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1709075 · Cited by 4
Zhou, Z., Zhao, K., Xiao, X., Yang, W., Miao, Y., Wu, T., Kong, X., Tao, Y., Wang, W., & Dong, Z. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105208 · Cited by 5
Acquired resistance of cancer therapies: Mechanisms and perspectives
Wang, M., Zhai, X., Li, J., Chen, J., Gai, X., Liu, X., Liu, Y., Zhou, Q., & Chen, C. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004048 · Cited by 5
Cholesterol metabolism in immune cells: From mechanisms to therapeutic opportunities
Yin, M., Liang, T., Zhang, Y., Wang, G., Yang, W., & Xu, C. (2026) · Immunity · doi:10.1016/j.immuni.2026.05.007 · Cited by 5
Advancing CAR-NK cell therapy in solid tumors: Current landscape and future directions
Manzar, G. S., Hasan, M. F., Moore, M., Tiberti, S., Puebla‐Osorio, N., Başar, R., & Daher, M. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102881 · Cited by 4
Stem Cell Therapy and Innate Lymphoid Cells
Verma, D., Verma, M., & Mishra, R. (2022) · Stem Cells International · doi:10.1155/2022/3530520 · Cited by 4
Natural killer loops: pyruvate in, lactate out
Keane, C., & Finlay, D. K. (2025) · Nature Metabolism · doi:10.1038/s42255-024-01195-5 · Cited by 4
Self-citationZhao, Y., Zhu, W., Dong, S., Zhang, H., & Zhou, W. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16873 · Cited by 5
Make killers sweeter: targeting metabolic checkpoints of NK cells
Wei, H., & Fu, B. (2020) · Nature Immunology · doi:10.1038/s41590-020-0738-x · Cited by 4
Rashidpour, A., Wu, Y., Almajano, M. P., Fàbregas, A., & Metón, I. (2023) · Marine Drugs · doi:10.3390/md21110562 · Cited by 4
Shi, Y., Du, J., Pan, W., Zhang, H., & Ba, Y. (2023) · journal of nutritional oncology · doi:10.1097/jn9.0000000000000008 · Cited by 5
Instruction of Immunometabolism by Adipose Tissue: Implications for Cancer Progression
Raja, R., Wu, C. W., Limbeck, F., Butler, K. A., Acharya, A. P., & Curtis, M. (2021) · Cancers · doi:10.3390/cancers13133327 · Cited by 4
Peng, Y., Cao, P., Liang, Y., Wang, C., & Tian, Y. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189430 · Cited by 3
Glycolytic diversity drives immune complexity in cancer
Wu, C.-Y., Huang, C.-X., Yuan, W., & Kuang, D. (2025) · Trends in Immunology · doi:10.1016/j.it.2025.11.002 · Cited by 4
Glucose metabolic reprogramming as a driver of immunosuppression in the tumour microenvironment
Wang, Y., Lu, Y., Zhou, J., & Yang, X. (2026) · Clinical and Translational Medicine · doi:10.1002/ctm2.70665 · Cited by 3
Foglia, B., Nurcis, J., Signorini, M., & Cannito, S. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1823145 · Cited by 3
Tang, W., Meng, F., Li, M., Li, Y., Xiong, W., Zhang, D., & Yang, B. (2023) · The Journal of Gene Medicine · doi:10.1002/jgm.3609 · Cited by 3
The metabolic drivers of IFN-γ release: glycolysis and acetyl CoA ride in the front seat
Henderson, J., & O’Reilly, S. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf045 · Cited by 4
Metadata
- Authors
- Assmann, N., O'Brien, K. L., Donnelly, R. P., Dyck, L., Zaiatz-Bittencourt, V., Loftus, R. M., Heinrich, P., Oefner, P. J., Lynch, L., Gardiner, C. M., Dettmer, K., & Finlay, D. K.
- Affiliations
- Trinity College Dublin (IE)
- University of Regensburg (DE)
- Corresponding author
- Finlay, David K
- ORCID
- Venue
- Nature Immunology
- Published
- 2017-09-18
- Volume
- 18
- Issue
- 11
- Pages
- 1197-1206
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2755907400
- Cited by
- 375
- References
- 57
- Citations by year
- 2026: 35 · 2025: 54 · 2024: 37 · 2023: 44 · 2022: 53 · 2021: 57 · 2020: 45 · 2019: 25 · 2018: 21 · 2017: 4
- FWCI
- 11.74
- Type
- journal article
- Language
- en
- Open access
- green
- zenodo.org
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- natural killer cells, SREBP, glucose metabolism, metabolic reprogramming, glycolysis, oxidative phosphorylation, interferon-gamma, NK cell cytotoxicity, cytokine activation, antitumor immunity, viral infection
- MeSH terms
- Animals, Flow Cytometry, Glucose, Glycolysis, Humans, Killer Cells, Natural, Lipids, Oxidative Phosphorylation, Immunoblotting, T-Lymphocyte Subsets, Cytokines, Cell Proliferation, Sterol Regulatory Element Binding Protein 1, Sterol Regulatory Element Binding Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review